Montesinos-Rongen et al., 2021 - Google Patents
Impact of a faulty germinal center reaction on the pathogenesis of primary diffuse large B cell lymphoma of the central nervous systemMontesinos-Rongen et al., 2021
View HTML- Document ID
- 1114717858601962569
- Author
- Montesinos-Rongen M
- Brunn A
- Sanchez-Ruiz M
- Küppers R
- Siebert R
- Deckert M
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Simple Summary The pathogenetic mechanisms and peculiar tropism of primary CNS lymphoma (PCNSL) of the central nervous system (CNS) have been the subject of debate for decades. Hypothesis-driven targeted molecular studies have revealed that PCNSLs …
- 210000003169 Central Nervous System 0 title abstract description 129
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Coccaro et al. | Next-generation sequencing in acute lymphoblastic leukemia | |
| Weiler et al. | Cell fusion in human cancer: the dark matter hypothesis | |
| Visco et al. | Oncogenic mutations of MYD88 and CD79B in diffuse large B-cell lymphoma and implications for clinical practice | |
| Montesinos-Rongen et al. | Impact of a faulty germinal center reaction on the pathogenesis of primary diffuse large B cell lymphoma of the central nervous system | |
| Crisà et al. | Atypical chronic myeloid leukemia: where are we now? | |
| Kaminska et al. | Single-cell omics in dissecting immune microenvironment of malignant gliomas—challenges and perspectives | |
| Todorovic Balint et al. | Gene mutation profiles in primary diffuse large B cell lymphoma of central nervous system: next generation sequencing analyses | |
| Vartholomatos et al. | The past, present and future of flow cytometry in central nervous system malignancies | |
| Ahmed et al. | Precision medicine in pediatric cancer: current applications and future prospects | |
| Zou et al. | Molecular heterogeneity and cellular diversity: implications for precision treatment in medulloblastoma | |
| Hutóczki et al. | Novel concepts of glioblastoma therapy concerning its heterogeneity | |
| Tucker et al. | The promise of patient-derived preclinical models to accelerate the implementation of personalised medicine for children with neuroblastoma | |
| Lopez-Nunez et al. | Melanotic neuroectodermal tumor of infancy (MNTI) and pineal anlage tumor (PAT) harbor a medulloblastoma signature by DNA methylation profiling | |
| Kiesewetter et al. | Genetic characterization and clinical features of helicobacter pylori negative gastric mucosa-associated lymphoid tissue lymphoma | |
| Yanguas-Casás et al. | An overview on diffuse large B-cell lymphoma models: towards a functional genomics approach | |
| Watt et al. | Heterogeneity in pancreatic cancer fibroblasts—tgfβ as a master regulator? | |
| Rocco et al. | Treatment of advanced non-small cell lung cancer with RET fusions: reality and hopes | |
| Lebel et al. | Understanding the bioactivity and prognostic implication of commonly used surface antigens in multiple myeloma | |
| López et al. | Molecular pathogenesis of follicular lymphoma: from genetics to clinical practice | |
| Dasgupta et al. | Preclinical models of low-grade gliomas | |
| Passariello et al. | PATZ1 is overexpressed in pediatric glial tumors and correlates with worse event-free survival in high-grade gliomas | |
| Pastorino et al. | Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology | |
| Nguyen et al. | H3G34-mutant gliomas—a review of molecular pathogenesis and therapeutic options | |
| Tosello et al. | A novel t (8; 14)(q24; q11) rearranged human cell line as a model for mechanistic and drug discovery studies of notch1-independent human T-cell leukemia | |
| Mellai et al. | Human tert promoter mutations in atypical and anaplastic meningiomas |